CA3051444A1 - Process utilizing pulsed energy to heat treat biological tissue - Google Patents
Process utilizing pulsed energy to heat treat biological tissue Download PDFInfo
- Publication number
- CA3051444A1 CA3051444A1 CA3051444A CA3051444A CA3051444A1 CA 3051444 A1 CA3051444 A1 CA 3051444A1 CA 3051444 A CA3051444 A CA 3051444A CA 3051444 A CA3051444 A CA 3051444A CA 3051444 A1 CA3051444 A1 CA 3051444A1
- Authority
- CA
- Canada
- Prior art keywords
- target tissue
- para
- tissue
- approximately
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 58
- 230000008569 process Effects 0.000 title claims abstract description 30
- 238000011282 treatment Methods 0.000 claims abstract description 194
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 228
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 228
- 238000002604 ultrasonography Methods 0.000 claims description 73
- 230000004913 activation Effects 0.000 claims description 56
- 230000002207 retinal effect Effects 0.000 claims description 32
- 230000001225 therapeutic effect Effects 0.000 abstract description 24
- 210000001519 tissue Anatomy 0.000 description 279
- 238000001994 activation Methods 0.000 description 54
- 210000004027 cell Anatomy 0.000 description 53
- 102000004169 proteins and genes Human genes 0.000 description 35
- 108090000623 proteins and genes Proteins 0.000 description 35
- 230000006378 damage Effects 0.000 description 30
- 230000005855 radiation Effects 0.000 description 29
- 230000000694 effects Effects 0.000 description 27
- 238000010521 absorption reaction Methods 0.000 description 25
- 230000003287 optical effect Effects 0.000 description 25
- 230000008901 benefit Effects 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 19
- 101100506686 Arabidopsis thaliana HSFA1B gene Proteins 0.000 description 18
- 101150017616 Hsf3 gene Proteins 0.000 description 18
- 101100071480 Oryza sativa subsp. japonica HSFA1 gene Proteins 0.000 description 18
- 230000005670 electromagnetic radiation Effects 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 16
- 230000006399 behavior Effects 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 15
- 230000005451 protein repair Effects 0.000 description 15
- 241000894007 species Species 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 101100421857 Caenorhabditis elegans sod-2 gene Proteins 0.000 description 13
- 230000001413 cellular effect Effects 0.000 description 13
- 210000001525 retina Anatomy 0.000 description 13
- 230000008439 repair process Effects 0.000 description 12
- 238000009792 diffusion process Methods 0.000 description 11
- 210000000624 ear auricle Anatomy 0.000 description 11
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 11
- 230000035939 shock Effects 0.000 description 11
- 230000014509 gene expression Effects 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 230000007423 decrease Effects 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000035515 penetration Effects 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000013307 optical fiber Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 230000000451 tissue damage Effects 0.000 description 7
- 231100000827 tissue damage Toxicity 0.000 description 7
- 230000027455 binding Effects 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000004936 stimulating effect Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000001086 cytosolic effect Effects 0.000 description 5
- 230000001066 destructive effect Effects 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 238000005286 illumination Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000006187 pill Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 4
- 108090000695 Cytokines Proteins 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 4
- 206010012689 Diabetic retinopathy Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 201000011190 diabetic macular edema Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 231100000518 lethal Toxicity 0.000 description 4
- 230000001665 lethal effect Effects 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 4
- 238000013021 overheating Methods 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 208000003569 Central serous chorioretinopathy Diseases 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 206010064930 age-related macular degeneration Diseases 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 230000003915 cell function Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000014951 hematologic disease Diseases 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000649 photocoagulation Effects 0.000 description 3
- 238000001126 phototherapy Methods 0.000 description 3
- 201000007914 proliferative diabetic retinopathy Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 239000013638 trimer Substances 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000004637 cellular stress Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003818 metabolic dysfunction Effects 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 210000001989 nasopharynx Anatomy 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000000246 remedial effect Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 210000001533 respiratory mucosa Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 230000004393 visual impairment Effects 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010071155 Autoimmune arthritis Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000018932 HSP70 Heat-Shock Proteins Human genes 0.000 description 1
- 108010027992 HSP70 Heat-Shock Proteins Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 208000001344 Macular Edema Diseases 0.000 description 1
- 206010025415 Macular oedema Diseases 0.000 description 1
- 206010064912 Malignant transformation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 206010057430 Retinal injury Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 101100291461 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spm2 gene Proteins 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000007960 cellular response to stress Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 201000008615 cone dystrophy Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000011325 dry age related macular degeneration Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000002839 fiber optic waveguide Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000010230 macular retinal edema Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036212 malign transformation Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000013533 micropulse laser treatment Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000633 nuclear envelope Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000004243 retinal function Effects 0.000 description 1
- 208000004644 retinal vein occlusion Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000007725 thermal activation Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N7/02—Localised ultrasound hyperthermia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0082—Scanning transducers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Otolaryngology (AREA)
- Medical Informatics (AREA)
- Optics & Photonics (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Electromagnetism (AREA)
- Plasma & Fusion (AREA)
- Pathology (AREA)
- Laser Surgery Devices (AREA)
- Radiation-Therapy Devices (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/460,821 | 2017-03-16 | ||
| US15/460,821 US20170203132A1 (en) | 2015-10-26 | 2017-03-16 | System and process utilizing pulsed energy to treat biological tissue |
| US15/583,096 US10953241B2 (en) | 2012-05-25 | 2017-05-01 | Process for providing protective therapy for biological tissues or fluids |
| US15/583,096 | 2017-05-01 | ||
| US15/629,002 US10278863B2 (en) | 2016-03-21 | 2017-06-21 | System and process for treatment of myopia |
| US15/629,002 | 2017-06-21 | ||
| US15/918,487 | 2018-03-12 | ||
| US15/918,487 US10874873B2 (en) | 2012-05-25 | 2018-03-12 | Process utilizing pulsed energy to heat treat biological tissue |
| PCT/US2018/022201 WO2018169969A1 (en) | 2017-03-16 | 2018-03-13 | Process utilizing pulsed energy to heat treat biological tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3051444A1 true CA3051444A1 (en) | 2018-09-20 |
Family
ID=63522526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3051444A Pending CA3051444A1 (en) | 2017-03-16 | 2018-03-13 | Process utilizing pulsed energy to heat treat biological tissue |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3595775A4 (ja) |
| JP (1) | JP7239990B2 (ja) |
| CN (1) | CN110520194B (ja) |
| AU (1) | AU2018236202B2 (ja) |
| BR (1) | BR112019017891A2 (ja) |
| CA (1) | CA3051444A1 (ja) |
| SG (1) | SG11201907081TA (ja) |
| WO (1) | WO2018169969A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI728589B (zh) | 2019-12-12 | 2021-05-21 | 國立臺灣大學 | 以熱作用於活體組織的方法及裝置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5445146A (en) * | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
| CN101242793A (zh) * | 2004-06-25 | 2008-08-13 | 生产力有限公司 | 抗病毒热疗法 |
| WO2007146342A2 (en) * | 2006-06-12 | 2007-12-21 | Ivivi Technologies, Inc. | Electromagnetism for prophylaxis and opthalmic tissue repair |
| US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
| US8141557B2 (en) * | 2008-10-22 | 2012-03-27 | Peyman Gholam A | Method of oscillatory thermotherapy of biological tissue |
| US9278029B2 (en) * | 2011-10-19 | 2016-03-08 | Iridex Corporation | Short duration pulse grid pattern laser treatment and methods |
| US10531908B2 (en) | 2012-05-25 | 2020-01-14 | Ojai Retinal Technology, Llc | Method for heat treating biological tissues using pulsed energy sources |
| US9381115B2 (en) | 2012-05-25 | 2016-07-05 | Ojai Retinal Technology, Llc | System and process for retina phototherapy |
| US9427602B2 (en) * | 2012-05-25 | 2016-08-30 | Ojai Retinal Technology, Llc | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair |
| US9962291B2 (en) * | 2012-05-25 | 2018-05-08 | Ojai Retinal Technology, Llc | System and process for neuroprotective therapy for glaucoma |
| JP2015527176A (ja) * | 2012-09-10 | 2015-09-17 | ダーマル フォトニクス コーポレイション | 使用補充のためのシステムおよび方法 |
| WO2014070699A1 (en) * | 2012-11-01 | 2014-05-08 | Seminex Corporation | Variable intensity laser treatments of the skin |
-
2018
- 2018-03-13 BR BR112019017891-0A patent/BR112019017891A2/pt unknown
- 2018-03-13 EP EP18766907.2A patent/EP3595775A4/en not_active Withdrawn
- 2018-03-13 WO PCT/US2018/022201 patent/WO2018169969A1/en unknown
- 2018-03-13 CA CA3051444A patent/CA3051444A1/en active Pending
- 2018-03-13 SG SG11201907081TA patent/SG11201907081TA/en unknown
- 2018-03-13 JP JP2019539181A patent/JP7239990B2/ja active Active
- 2018-03-13 AU AU2018236202A patent/AU2018236202B2/en active Active
- 2018-03-13 CN CN201880017624.0A patent/CN110520194B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3595775A1 (en) | 2020-01-22 |
| CN110520194B (zh) | 2024-03-26 |
| BR112019017891A2 (pt) | 2020-05-12 |
| AU2018236202A1 (en) | 2019-08-29 |
| CN110520194A (zh) | 2019-11-29 |
| SG11201907081TA (en) | 2019-09-27 |
| AU2018236202B2 (en) | 2020-11-05 |
| WO2018169969A1 (en) | 2018-09-20 |
| JP7239990B2 (ja) | 2023-03-15 |
| JP2020511189A (ja) | 2020-04-16 |
| EP3595775A4 (en) | 2020-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9427602B2 (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| US10531908B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US20170203132A1 (en) | System and process utilizing pulsed energy to treat biological tissue | |
| AU2020213374B2 (en) | Method for heat treating biological tissues using pulsed energy sources | |
| US11033749B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| CA2972416C (en) | Pulsating electromagnetic and ultrasound therapy for stimulating targeted heat shock proteins and facilitating protein repair | |
| US20210346712A1 (en) | System and process of utilizing microwave energy for treating biological tissue | |
| AU2018236202B2 (en) | Process utilizing pulsed energy to heat treat biological tissue | |
| AU2017308587A1 (en) | Process for providing protective therapy for biological tissues or fluids | |
| US20230103544A1 (en) | System and process for utilizing energy for neuroregeneration | |
| CA3091103A1 (en) | System and process of utilizing energy for treating biological tissue | |
| EP3745972A1 (en) | System and process of utilizing energy for treating biological tissue | |
| WO2024118164A1 (en) | System and process for utilizing energy for neuroregeneration | |
| WO2018169560A1 (en) | System and process utilizing pulsed energy to treat biological tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |
|
| EEER | Examination request |
Effective date: 20220325 |